Pillstats
Rx only · Injection · Intravenous

Carboplatin

Brands: Kyxata · Carboplatin

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL01XA02
RxCUI (US)40048
US makers2 labelers
Packages6
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6681.3K2.0K2.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
833
Rx · 2026 Q1
35K
Units dispensed
-39%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Accord Healthcare Inc.unknown4SUPPLYING
Avyxa Pharma, LLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 28, 2023
    SHORTAGEDrug shortage: Carboplatin Injection (Accord Healthcare Inc.)

    Carboplatin Injection — reported in shortage by Accord Healthcare Inc.. Therapeutic category: Oncology.

  • Apr 28, 2023
    SHORTAGEDrug shortage: Carboplatin Injection (Avyxa Pharma, LLC)

    Carboplatin Injection — reported in shortage by Avyxa Pharma, LLC. Therapeutic category: Oncology.